Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daren Graham Insider Profile
4 Followers
Daren Graham, Director, Ten Percent Owner at GeneTether Therapeutics, Inc., holds 8.83M shares in GeneTether Therapeutics, Inc. (Ticker: TSE:GTTX). Most recently, Daren Graham Bought C$6,398,359 shares of GeneTether Therapeutics, Inc. on Jan 09, 2025 for an estimated value of 127.97K.
Daren Graham has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director, Ten Percent Owner
Roles that Daren Graham holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daren Graham
Daren Graham's Trading History
List of latest transactions for each holding click on a transaction to see Daren Graham's performance on stock
You May Also Like
Daren Graham insider profile FAQ
What is the percentage of profitable transactions made by Daren Graham?
The percentage of profitable transactions made by Daren Graham is ―.
What is the average return per transaction made by Daren Graham?
The average return per transaction made by Daren Graham is ―.
What stocks does Daren Graham hold?
Daren Graham holds: TSE:GTTX stocks.
What was Daren Graham’s latest transaction?
Daren Graham latest transaction was an Informative Buy of C$127.97K.
What was Daren Graham's most profitable transaction?
Daren Graham’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daren Graham's role in GeneTether Therapeutics, Inc.?
Daren Graham's role in GeneTether Therapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.